137 related articles for article (PubMed ID: 37585664)
1. A novel dose-adjustment protocol for interrupted subcutaneous immunotherapy for allergic rhinitis.
Feng X; Liu J
Immunotherapy; 2023 Oct; 15(14):1171-1181. PubMed ID: 37585664
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of subcutaneous house dust mite immunotherapy in patients with moderate to severe allergic rhinitis.
Valero A; Ibáñez-Echevarría E; Vidal C; Raducan I; Castelló Carrascosa JV; Sánchez-López J
Immunotherapy; 2022 Jun; 14(9):683-694. PubMed ID: 35465692
[TBL] [Abstract][Full Text] [Related]
3. [Intradermal immunotherapy with low-dose house dust mite allergens in patients with allergic rhinitis: A proof-of-concept study].
Vieira-Hernández A; Capriles-Hulett A; Sánchez-Borges M; Fabiano F; Albarrán-Barrios C
Rev Alerg Mex; 2018; 65(1):41-51. PubMed ID: 29723940
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy comparison and safety analysis of subcutaneous specific immunotherapy with standardized house dust mite allergen in patients with single and multiple allergic rhinitis].
Huang HH; Xu C; Liu L; Chai RN
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):774-783. PubMed ID: 35785859
[No Abstract] [Full Text] [Related]
5. Sublingual immunotherapy in patients with house dust mite allergic rhinitis: prospective study of clinical outcomes over a two-year period.
Soh JY; Thalayasingam M; Ong S; Loo EX; Shek LP; Chao SS
J Laryngol Otol; 2016 Mar; 130(3):272-7. PubMed ID: 26781592
[TBL] [Abstract][Full Text] [Related]
6. House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.
Richards JR; Stumpf JL
Ann Pharmacother; 2018 Oct; 52(10):1019-1030. PubMed ID: 29642713
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of allergen-specific subcutaneous immunotherapy for house dust mite induced allergic rhinitis.
Sahin E; Dizdar D; Dinc ME; Cirik AA
J Laryngol Otol; 2017 Nov; 131(11):997-1001. PubMed ID: 29037263
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Subcutaneous and Sublingual Immunotherapy for House Dust Mite Allergy: A Network Meta-Analysis-Based Comparison.
Kim JY; Jang MJ; Kim DY; Park SW; Han DH
J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4450-4458.e6. PubMed ID: 34464748
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of standardised specific subcutaneous immunotherapy in children with persistent allergic rhinitis due to multiple allergens including house dust mites.
Song Y; Long J; Wang T; Xie J; Wang M; Tan G
J Laryngol Otol; 2018 Mar; 132(3):230-235. PubMed ID: 29374499
[TBL] [Abstract][Full Text] [Related]
10. The changes in different symptom scores during subcutaneous immunotherapy in Chinese house dust mite allergic patients: a two-year, observational study.
Tu Y; Zhang H; Zhao L; Jin P; Zi X; Li T; Shi L; Zhi L
J Laryngol Otol; 2019 Mar; 133(3):213-219. PubMed ID: 30674357
[TBL] [Abstract][Full Text] [Related]
11. A Cost-Minimisation Analysis Comparing Sublingual Immunotherapy to Subcutaneous Immunotherapy for the Treatment of House Dust Mite Allergy in a Swedish Setting.
Björstad Å; Cardell LO; Hahn-Pedersen J; Svärd M
Clin Drug Investig; 2017 Jun; 37(6):541-549. PubMed ID: 28326466
[TBL] [Abstract][Full Text] [Related]
12. [Observation and analysis of systemic reactions to house dust mite subcutaneous immunotherapy in 362 patients with allergic rhinitis].
Xue JR; Ma J; Qiu CY; Hu ZB; Jiang X; Pan M; Lu MP; Cheng L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 May; 55(5):445-451. PubMed ID: 32842357
[No Abstract] [Full Text] [Related]
13. SQ house dust mite sublingual immunotherapy for the treatment of adults with house dust mite-induced allergic rhinitis.
Meteran H; Backer V
Expert Rev Clin Immunol; 2019 Nov; 15(11):1127-1133. PubMed ID: 31584839
[No Abstract] [Full Text] [Related]
14. Cost-minimization analysis of sublingual immunotherapy versus subcutaneous immunotherapy for house dust mite respiratory allergic disease in Denmark.
Rønborg S; Johnsen CR; Theilgaard S; Winther A; Hahn-Pedersen J; Andreasen JN; Olsen J
J Med Econ; 2016 Aug; 19(8):735-41. PubMed ID: 26909663
[TBL] [Abstract][Full Text] [Related]
15. Recent development on the use of sublingual immunotherapy tablets for allergic rhinitis.
Waserman S; Shah A; Avilla E
Ann Allergy Asthma Immunol; 2021 Aug; 127(2):165-175.e1. PubMed ID: 34029713
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB
J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762
[TBL] [Abstract][Full Text] [Related]
17. [Comparison study of subcutaneous immunotherapy and sublingual immunotherapy in patients with allergic rhinitis].
You SH; Qin XY; Xu C; Qiu X; Luan ZL; Jia HX; Wang HT
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(9):689-693. PubMed ID: 29771014
[No Abstract] [Full Text] [Related]
18. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of sublingual immunotherapy for house dust mite-induced allergic rhinitis and its co-morbid conditions.
Chan AW; Luk WP; Fung LH; Lee TH
Immunotherapy; 2019 Nov; 11(16):1387-1397. PubMed ID: 31608757
[No Abstract] [Full Text] [Related]
20. Long-term safety of subcutaneous immunotherapy with TO-204 in Japanese patients with house dust mite-induced allergic rhinitis and allergic bronchial asthma: Multicenter, open label clinical trial.
Fujisawa T; Shimoda T; Masuyama K; Okubo K; Honda K; Okano M; Katsunuma T; Urisu A; Kondo Y; Odajima H; Kurihara K; Nagata M; Taniguchi M; Taniuchi S; Doi S; Matsumoto T; Hashimoto S; Tanaka A; Natsui K; Abe N; Ozaki H
Allergol Int; 2018 Jul; 67(3):347-356. PubMed ID: 29233461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
